Literature DB >> 30446051

Recognition, Diagnostics, and Management of Pediatric Severe Sepsis and Septic Shock in the Emergency Department.

Raina Paul1.   

Abstract

Several new studies have emerged in recent years that have attempted to aid emergency department providers in recognizing and treating pediatric patients with severe sepsis and septic shock. National guidelines and supporting literature are unanimous in recommendations that early recognition and timely therapeutics are necessary for improved survival and decreased morbidity. The literature is less concrete in defining how emerging advances in the field can aid in time-sensitive care of these patients. This article summarizes the recent literature as it pertains to the initial presentation of severe sepsis and septic shock in the pediatric patient within the emergency department.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Resuscitation; Sepsis; Septic shock; Severe sepsis

Mesh:

Substances:

Year:  2018        PMID: 30446051     DOI: 10.1016/j.pcl.2018.07.012

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  3 in total

1.  CADDIE2-evaluation of a clinical decision-support system for early detection of systemic inflammatory response syndrome in paediatric intensive care: study protocol for a diagnostic study.

Authors:  Antje Wulff; Sara Montag; Bianca Steiner; Michael Marschollek; Philipp Beerbaum; André Karch; Thomas Jack
Journal:  BMJ Open       Date:  2019-06-19       Impact factor: 2.692

2.  Neutrophil-to-lymphocyte ratio as a predictive marker for severe pediatric sepsis.

Authors:  Xi Zhong; Aijia Ma; Zhongwei Zhang; Yong Liu; Guopeng Liang
Journal:  Transl Pediatr       Date:  2021-03

3.  The effect of subdiaphragmatic vagotomy on heart rate variability and lung inflammation in rats with severe hemorrhagic shock.

Authors:  Fateme Khodadadi; Farzaneh Ketabchi; Zahra Khodabandeh; Alireza Tavassoli; Gregory F Lewis; Aminollah Bahaoddini
Journal:  BMC Cardiovasc Disord       Date:  2022-04-19       Impact factor: 2.174

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.